Curcumin inhibited hepatitis B viral entry through NTCP binding
Abstract Hepatitis B virus (HBV) has been implicated in hepatitis and hepatocellular carcinoma. Current agents (nucleos(t)ide analogs and interferons) could only attenuate HBV infection. A combination of agents targeting different stages of viral life cycle (e.g., entry, replication, and cccDNA stab...
Guardado en:
Autores principales: | Piyanoot Thongsri, Yongyut Pewkliang, Suparerk Borwornpinyo, Adisak Wongkajornsilp, Suradej Hongeng, Khanit Sa-ngiamsuntorn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7dea2b7df0b440859e7298ba57146554 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection
por: Takuro Uchida, et al.
Publicado: (2021) -
Hepatitis viral
por: Suárez G,Mónica
Publicado: (1976) -
Hepatitis Viral
por: Sepúlveda C,Cecilia
Publicado: (2009) -
Neural stem cell-derived exosomes mediate viral entry
por: Sims B, et al.
Publicado: (2014) -
Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry
por: Dhiraj Mannar, et al.
Publicado: (2021)